Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial. (Q40521722)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Giulia Valeria Bianchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ana Lluch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Luca Gianni

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

G Bianchini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

L Pusztai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Y-H Im

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

L-M Tseng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M-C Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

E Galeota

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

D Magazzù

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

J de la Haba-Rodríguez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

D-Y Oh

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

B Poirier

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

J L Pedrini

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

V Semiglazov

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

P Valagussa

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

19 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

2429-2436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

The immune system and response to HER2-targeted treatment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parall

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

The emerging role of immunosurveillance in dictating metastatic spread in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

The two faces of interferon-γ in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Molecular mechanisms of T cell co-stimulation and co-inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Tumor-associated immune parameters for personalized patient care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Programmed death ligand-1 expression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV395

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDV395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json

release_ysy453qduvepjjvkalpmtvg63q

24 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ysy453qduvepjjvkalpmtvg63q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26387142%20AND%20SRC:MED&resulttype=core&format=json